aTyr Pharma, Inc.
LIFE
|
$1.63
1.88%
1.84%
290K
|
Health Technology
(0.0% 1d) (-14.6% 1m) (-23.7% 1y) (0.0% 2d) (0.0% 3d) (3.1% 7d) (84.57% volume)
Earnings Calendar: 2024-03-14
Market Cap: $ 110,743,571
http://www.atyrpharma.com
Sec Filling | Patents | 44 employees
(US) aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. It operates in a single accounting segment. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
glass diagnostics
add to watch list Paper trade email alert is off
Press-releases
aTyr Pharma to Participate in April Investor Conferences
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: -3.05%
pharma
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: 0.0%
H: 24.07%
C: 22.84%
pharma year update results
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: -5.0%
pharma conference year financial results
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
Published: 2024-02-21 (Crawled : 13:00) - globenewswire.com
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: 1.6%
H: 5.24%
C: 3.14%
pharma program trial
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: 0.0%
H: 3.16%
C: 2.53%
pharma cell
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
Published: 2024-01-18 (Crawled : 13:00) - globenewswire.com
WDAY S | $253.54 0.52% 0.52% 1.1M
|
Technology Services
|
| O: 0.71%
H: 0.87%
C: 0.84%
PODD | $164.46 -1.08% -1.09% 680K
|
Health Technology
|
| O: 0.95%
H: 0.87%
C: 0.54%
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: -4.05%
pharma
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: -1.79%
H: 6.36%
C: 1.36%
pharma preclinical efzofitimod
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: 0.87%
H: 0.86%
C: -3.45%
pharma update results
Sarcoidosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Key Players - Pfizer, United Therapeutics, Xentria, aTyr Pharma, Kyorin Pharmaceutical, Novartis, Kinevant Sciences
Published: 2023-11-02 (Crawled : 21:00) - prnewswire.com
UTHR | $234.03 -1.64% -1.67% 550K
|
Health Technology
|
| O: 0.73%
H: 0.63%
C: -2.35%
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: 0.78%
H: 1.54%
C: 0.0%
sciences growth market
aTyr Pharma to Present at November Investor Conferences
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
LIFE | $1.63 1.88% 1.84% 290K
|
Health Technology
|
| O: 5.6%
H: 0.0%
C: -6.82%
pharma
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Last 48 Hours Insiders Buying
MCFT P 26039 | $21.5 1.9% 1.86% 110K
|
Consumer Durables
|
00:00
YORW P 29 | $35.43 1.03% 1.02% 66K
|
Utilities
|
19:01
VUZI P 14500 | $1.35 11.57% 10.37% 890K
|
Electronic Technology
|
17:00
BANF P 256 | $91.28 2.24% 2.18% 150K
|
Finance
|
15:30
RMCF | $3.56 0.28% 0.28% 11K
|
Consumer Non-Durables
|
20:10